Qube Research & Technologies LTD Solid Biosciences Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.51 - $7.56 $1,790 - $26,535	-3,510 Reduced 5.85%	56,471 $26,000
Q2 2022 Aug 15, 2022	BUY	$0.43 - $1.24 $25,791 - $74,376	59,981 New	59,981 $37,000
Q3 2021 Nov 12, 2021	SELL	$2.38 - $3.77 $235,860 - $373,610	-99,101 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.49 - $5.51 $207,483 - $327,575	59,451 Added 149.94%	99,101 $363,000
Q1 2021 May 14, 2021	BUY	$5.37 - $10.72 $212,920 - $425,048	39,650 New	39,650 $219,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.